STAT+: Tobacco giant Philip Morris is investing billions in health care. Critics say it’s peddling cures for its own poison
A new health care company was quietly incorporated last month, with plans to leverage cutting-edge inhalation technology and oral delivery expertise to treat everything from neurology to cardiovascular emergencies.
The multibillion-dollar company, Vectura Fertin Pharma, stands out not simply for its ambitions, but because of its financial backer: Philip Morris International, the tobacco behemoth whose cigarettes are sold in more than 180 countries.
Continue to STAT+ to read the full story…
